Transparent financial reporting, strategic growth metrics, and long-term value creation in global biopharma, medical devices, and digital health.
Q4 2025 & Full Year Performance Metrics
Access quarterly earnings, 10-K/10-Q filings, proxy statements, and press releases.
| Date | Title | Type | Link |
|---|---|---|---|
| Feb 12, 2026 | Q4 2025 Earnings Press Release | Press Release | Download PDF → |
| Feb 10, 2026 | Quarterly Report (Q4 2025) | 10-Q | Download PDF → |
| Mar 15, 2025 | Annual Report (FY 2024) | 10-K | Download PDF → |
| Jan 28, 2025 | Definitive Proxy Statement | DEF 14A | Download PDF → |
| Dec 12, 2024 | 8-K: Acquisition of NeuroSynth Biologics | 8-K | Download PDF → |
Measurable outcomes driving sustainable value and patient-centered innovation.
Upcoming earnings calls, annual meetings, and roadshows.
Webcast & Live Q&A with CFO Dr. Elena Rostova
Zenth Tower, Neo Geneva / Virtual attendance available
London, Zurich, Milan, Paris | Institutional & Retail sessions
For shareholder inquiries, media requests, or presentation materials, reach out to our dedicated IR team.
Submit Inquiry →